Premium
Different tocolytics appear equally safe long‐term but we need both higher follow‐up rates and placebo‐controlled trials in future
Author(s) -
Thornton JG
Publication year - 2020
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.16230
Subject(s) - nifedipine , medicine , placebo , odds ratio , tocolytic agent , pediatrics , odds , randomized controlled trial , pregnancy , obstetrics , logistic regression , gestation , preterm labor , alternative medicine , biology , genetics , calcium , pathology